Chapter

Functional status and symptom associations (PCFS)

From Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports by Sambif

Concepts

1. 2021 Limitations

   "In 2021, greater functional limitation (PCFS ≥ 2) was associated with a higher burden of persistent cardiorespiratory and neurocognitive symptoms (Supplementary Table S14).\n\nIn the multivariable mo

2. 2024 Limitations

   "In 2024, for depressive symptoms we observed the largest association with functional limitation (aOR, 8.02; 95% CI 3.20–20.05), followed by rash (aOR, 6.43; 95% CI 1.73–23.90), headache (aOR, 5.03; 9

3. Consistent Associations

   "Together, these results indicate that fatigue, dyspnea, joint pain and depressive or cognitive symptoms were consistently associated with functional limitation across both follow-up periods (Table 2)